M05.052 Felty's syndrome, left hip

Name of the Condition

• Felty's syndrome, left hip

Summary

Felty's syndrome is a rare complication of rheumatoid arthritis characterized by the triad of rheumatoid arthritis, splenomegaly (enlarged spleen), and neutropenia (low neutrophil count). When affecting the left hip, it involves chronic inflammation of the left hip joint alongside systemic manifestations. The condition typically occurs in individuals with long-standing, severe rheumatoid arthritis and is associated with increased susceptibility to infections due to neutropenia.

Causes

Felty's syndrome is considered a variant of rheumatoid arthritis, though its exact cause is not fully understood. It is thought to result from chronic inflammation and immune dysregulation, leading to splenic sequestration of neutrophils and bone marrow suppression. The condition is strongly associated with high titers of rheumatoid factor and anti-citrullinated protein antibodies (ACPA). Hip involvement occurs as part of the broader rheumatoid arthritis process affecting multiple joints.

Risk Factors

• Long-standing, severe rheumatoid arthritis
• High titers of rheumatoid factor
• Presence of anti-citrullinated protein antibodies (ACPA)
• Advanced age (typically over 50 years)
• Female gender (more commonly affected)

Symptoms

• Persistent joint pain, swelling, and stiffness in the left hip from underlying rheumatoid arthritis
• Fatigue and weakness
• Recurrent infections due to neutropenia
• Abdominal discomfort or fullness from splenomegaly
• Unexplained weight loss
• Skin discoloration or ulcers (less common)

Diagnosis

Diagnosis of Felty's syndrome with left hip involvement requires confirmation of the triad of rheumatoid arthritis, splenomegaly, and neutropenia, along with evidence of left hip joint inflammation. Clinical evaluation includes assessing joint symptoms, splenic size, and blood counts. Laboratory tests may show neutropenia, anemia, or thrombocytopenia. Imaging of the left hip (e.g., X-ray or MRI) can confirm joint damage. Rheumatoid factor and anti-citrullinated protein antibodies are typically positive, supporting the diagnosis.

Treatment Options

Treatment focuses on managing rheumatoid arthritis and its complications. Disease-modifying antirheumatic drugs (DMARDs) are used to control joint inflammation. Granulocyte colony-stimulating factor (G-CSF) may be prescribed to address neutropenia and reduce infection risk. Splenectomy is rarely considered. Hip-specific interventions, such as physical therapy or joint replacement, may be needed for severe joint damage. Infections are treated promptly due to increased susceptibility.

Prognosis and Follow-Up

Prognosis depends on the severity of rheumatoid arthritis and response to treatment. Early intervention can improve outcomes, but long-term complications like infections or joint damage may occur. Regular monitoring of blood counts, joint function, and splenic size is essential. Follow-up care includes rheumatology and orthopedic evaluations to manage both systemic and hip-specific issues.

Complications

• Increased risk of serious infections due to neutropenia
• Progressive joint damage in the left hip, potentially leading to disability
• Anemia or thrombocytopenia from bone marrow involvement
• Splenic rupture (rare)
• Reduced quality of life from chronic pain and fatigue

Lifestyle & Prevention

• Maintain regular rheumatology follow-up to monitor disease activity
• Practice good hygiene to reduce infection risk
• Engage in gentle exercise to preserve joint function
• Avoid smoking, which worsens rheumatoid arthritis
• Ensure vaccinations (e.g., influenza, pneumococcal) are up to date, as advised by a healthcare provider

When to Seek Professional Help

Seek immediate medical attention for:

• Signs of infection (fever, chills, or unexplained illness)
• Sudden severe hip pain or swelling
• Unexplained bruising or bleeding (possible thrombocytopenia)
• Persistent fatigue or weight loss
• Abdominal pain or rapid enlargement of the spleen

Tips for Medical Coders

Document the left hip involvement and confirm the triad of rheumatoid arthritis, splenomegaly, and neutropenia to support the diagnosis. Ensure clinical notes specify the affected site (left hip) and any associated complications. Code M05.052 is specific to Felty's syndrome with left hip involvement; do not use this code for bilateral or unspecified hip involvement. Verify that documentation aligns with the ICD-10-CM coding guidelines for site-specific conditions.